John Nicholson, SVP & Chief Operating Officer at NEKTAR THERAPEUTICS (NKTR), sold 63,000 shares at $42.82 ($2.7M) on 2019-01-28, disclosed to the SEC on 2019-01-30.
Open-market sale of $2.7M NKTR by SVP & Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NKTR | SELL | 2019-02-21 | $324K | — | Filing → |
| NKTR | SELL | 2018-11-19 | $458K | — | Filing → |
| NKTR | SELL | 2018-05-18 | $820K | — | Filing → |